In a groundbreaking advancement at the crossroads of immunotherapy and regenerative medicine, researchers have unveiled an innovative drug delivery system…
2026 kicked off with a stream of AI platform deals across pharma, signaling a cultural shift away from single-asset bets and toward investment in AI infrastructure for broad discovery. The collaborations…